Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia
Marisa R. Morrow, Battsetseg Batchuluun, Jianhan Wu, Elham Ahmadi, Julie M. Leroux, Pedrum Mohammadi‐Shemirani, Eric M. Desjardins, Zhichao Wang, Evangelia E. Tsakiridis, Declan C.T. Lavoie, Amir Reihani, Brennan K. Smith, Jacek M. Kwiecień, James Lally, Tracy L. Nero, Michael W. Parker, Kjetil Ask, John W. Scott, Lei Jiang, Guillaume Paré, Stephen L. Pinkosky, Gregory R. Steinberg
Topics & Concepts
ATP citrate lyaseSteatohepatitisLipogenesisCitrate synthaseSteatosisFatty liverDyslipidemiaFibrosisAcetyl-CoA carboxylaseBiochemistryBiologyPyruvate carboxylaseChemistryEndocrinologyInternal medicineLipid metabolismMedicineEnzymeDiabetes mellitusDiseaseLiver Disease Diagnosis and TreatmentPeroxisome Proliferator-Activated ReceptorsEndoplasmic Reticulum Stress and Disease